Amyloidosis is a rare condition defined by the abnormal production of proteins that bind together to form amyloid proteins.

The new understanding of molecular events that drive the various forms of amyloidosis has generated treatment strategies that ...

This clearance makes EchoGo ® Amyloidosis the first commercially available software-only medical device to facilitate detection of Cardiac Amyloidosis using echocardiography. Requiring a single ...

Endomyocardial biopsy is the only method by which the presence of cardiac amyloidosis can be directly established in cardiac amyloidosis, but this method is invasive, expensive and not always ...

Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins can develop and grow in the heart tissue, increasing your risk for ...

20, 2024 /PRNewswire/ -- Ultromics' EchoGo ® Amyloidosis, clinical AI for echocardiography with the potential to revolutionize early detection of Cardiac Amyloidosis, has received US Food and ...

Amyloidosis occurs when the body produces abnormal proteins that bind together to form a substance called amyloid. Amyloids ...